| Home Visiting Doctors & Nurses Company | |
|
201 N Brand Blvd Unit 200 Glendale CA 91203-3590 | |
| (747) 272-7109 | |
| Not Available |
| Full Name | Home Visiting Doctors & Nurses Company |
|---|---|
| Speciality | General Practice |
| Location | 201 N Brand Blvd Unit 200, Glendale, California |
| Authorized Official Name and Position | Nellie Reyes Schwab (CEO) |
| Authorized Official Contact | 7472727109 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Home Visiting Doctors & Nurses Company 201 N Brand Blvd Unit 200 Glendale CA 91203-3590 Ph: (747) 272-7109 | Home Visiting Doctors & Nurses Company 201 N Brand Blvd Unit 200 Glendale CA 91203-3590 Ph: (747) 272-7109 |
| NPI Number | 1366105546 |
|---|---|
| Provider Enumeration Date | 10/15/2021 |
| Last Update Date | 05/05/2022 |
| Medicare PECOS PAC ID | 2961889472 |
|---|---|
| Medicare Enrollment ID | O20220520002065 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Individuals at the end of their life who use a sitting service to avoid being alone while dying or to give respite to family members who are caring for them, are significantly more likely to die at home than those who do not use such a service, report researchers.
This year's New York Festivals' Global Awards saw Grey Group Singapore sweep the healthcare awards including clinching the prestigious Grand Global award, five Global awards and three finalist certificates.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366105546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 208D00000X | General Practice | (* (Not Available)) | Primary |
| Provider Name | Lilibeth O Ramirez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497964688 PECOS PAC ID: 0446497655 Enrollment ID: I20130507000625 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Individuals at the end of their life who use a sitting service to avoid being alone while dying or to give respite to family members who are caring for them, are significantly more likely to die at home than those who do not use such a service, report researchers.
This year's New York Festivals' Global Awards saw Grey Group Singapore sweep the healthcare awards including clinching the prestigious Grand Global award, five Global awards and three finalist certificates.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
› Verified 8 days ago
| Provider Name | Catherine Noel-uyloan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891891537 PECOS PAC ID: 5698152106 Enrollment ID: I20220622002322 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Individuals at the end of their life who use a sitting service to avoid being alone while dying or to give respite to family members who are caring for them, are significantly more likely to die at home than those who do not use such a service, report researchers.
This year's New York Festivals' Global Awards saw Grey Group Singapore sweep the healthcare awards including clinching the prestigious Grand Global award, five Global awards and three finalist certificates.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
› Verified 8 days ago
News Archive
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Individuals at the end of their life who use a sitting service to avoid being alone while dying or to give respite to family members who are caring for them, are significantly more likely to die at home than those who do not use such a service, report researchers.
This year's New York Festivals' Global Awards saw Grey Group Singapore sweep the healthcare awards including clinching the prestigious Grand Global award, five Global awards and three finalist certificates.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
› Verified 8 days ago
Silva Karchikian, M.d. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 410 Arden Ave, Suite 101, Glendale, CA 91203 Phone: 818-549-9305 Fax: 818-662-8812 | |
Glendale Premier Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W Eulalia St, #201, Glendale, CA 91204 Phone: 818-240-0601 Fax: 818-240-0687 | |
Glenoaks Urgent Care Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1100 W Glenoaks Blvd, Glendale, CA 91202 Phone: 818-242-3333 Fax: 818-546-1056 | |
Rubin Manavi, Md, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 N Central Ave, Glendale, CA 91203 Phone: 818-241-0970 Fax: 818-638-0024 | |
Armen Nercessian Do Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1122 N Brand Blvd Ste 101, Glendale, CA 91202 Phone: 818-552-2011 Fax: 818-552-2012 | |
Synergy Observation Specialists Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Andy Chen M.d. A,medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1101 N Pacific Ave Ste 104, Glendale, CA 91202 Phone: 818-552-5000 Fax: 818-552-2959 |